Drug that blocks multiple coronavirus variants in mice identified
The Hindu
A newly-developed drug molecule called diABZI, which is currently being tested in clinical trials to treat some cancers, could inhibit SARS-CoV-2 infection of diverse strains
Scientists have identified a new drug which is highly effective in preventing severe COVID-19 in mice infected with SARS-CoV-2, and could also treat other respiratory coronaviruses. , published in the journal Science Immunology, suggest that the drug diABZI activates the body's innate immune response, the first line of defence against invading pathogens. "This paper is the first to show that activating an early immune response therapeutically with a single dose is a promising strategy for controlling the virus, including the South African variant B.1.351, which has led to worldwide concern," said Sara Cherry, a professor at the University of Pennsylvania in the U.S.More Related News